<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="covid_vaccine/PMC7462898/results/search/disease/results.xml">
  <result pre="prevention of COVID-19. Abstract Coronavirus disease-19 (COVID-19) is caused by" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is closely related to two"/>
  <result pre="breakouts in humans in the last 2 decades, namely, severe" exact="acute respiratory distress syndrome" post="coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV)."/>
  <result pre="global impact. The disease is caused by a coronavirus called" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) [1]. COVID-19 along with severe acute"/>
  <result pre="respiratory syndrome coronavirus 2 (SARS-CoV-2) [1]. COVID-19 along with severe" exact="acute respiratory distress syndrome" post="(SARS) and Middle East respiratory syndrome (MERS) are the"/>
  <result pre="are involved not only in viral replication but also in" exact="suppression" post="of the host defenses by various mechanisms, including degradation"/>
  <result pre="of mechanisms to evade detection by the host-immune response, including" exact="suppression" post="of host interferon response, mimicking host 5â€™ cap on"/>
  <result pre="COVID-19, including age, biological sex, pre-existing medical conditions, such as" exact="cardiovascular disease," post="diabetes, and obesity. Otherwise, the reasons for: inter-individual variability"/>
  <result pre="comorbid conditions. About 5% of the infected symptomatic patients develop" exact="acute respiratory distress syndrome" post="and require oxygen supplementation through intubation and other invasive"/>
  <result pre="and partly because of the presence of concomitant cardiovascular diseases," exact="diabetes mellitus" post="and others. Although males and females are equally susceptible"/>
  <result pre="SARS-CoV-2 depends on coexpression of ACE2 and host proteases, viral" exact="myocarditis" post="is not a common feature of COVID-19. However, histological"/>
  <result pre="thrombosis, and heart failure (reviewed in [33,34,35]). More importantly, concomitant" exact="cardiovascular disease" post="and secondary cardiac involvement are major determinants of clinical"/>
  <result pre="patients with COVID-19 [36,37]. Coagulopathy, represented by increased D-Dimer levels," exact="disseminated intravascular coagulation" post="(DIC), and thrombocytopenia, and thrombotic events, is a common"/>
  <result pre="available and are currently being used for treatment of chronic" exact="pancreatitis" post="and cystic fibrosis, respectively. Preclinical studies show treatment with"/>
  <result pre="are currently being used for treatment of chronic pancreatitis and" exact="cystic fibrosis," post="respectively. Preclinical studies show treatment with camostat mesylate blocks"/>
  <result pre="vector, such as plasmids, replication-deficient adenoviruses, lentiviruses, or replication-competent vesicular" exact="stomatitis" post="virus, to transfer a SARS-CoV-2 gene and express a"/>
  <result pre="classic antigens for vaccine generation, dating back to vaccination against" exact="smallpox" post="by Edward Jenner who coined the term vaccination. The"/>
  <result pre="of diseases. Declaration of competing interest None. References References 1ZhouPYangXLWangXGHuBZhangLZhangWA" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
  <result pre="of probable bat originNature579202027027332015507 2WuFZhaoSYuBChenYMWangWSongZGA new coronavirus associated with human" exact="respiratory disease" post="in ChinaNature579202026526932015508 3BartlamMYangHRaoZStructural insights into SARS coronavirus proteinsCurr Opin"/>
  <result pre="spike glycoproteinCell1812020281292e632155444 5ShangJYeGShiKWanYLuoCAiharaHStructural basis of receptor recognition by SARS-CoV-2Nature581202022122432225175 6DeDiegoMLAlvarezEAlmazanFRejasMTLamirandeERobertsAA" exact="severe acute respiratory syndrome" post="coronavirus that lacks the E gene is attenuated in"/>
  <result pre="and only proteolysis by TMPRSS2 augments entry driven by the" exact="severe acute respiratory syndrome" post="coronavirus spike proteinJ Virol8820141293130724227843 14ZieglerCGKAllonSJNyquistSKMbanoIMMiaoVNTzouanasCNSARS-CoV-2 receptor ACE2 is an"/>
  <result pre="and population levelsmedRxiv.2020, 2020.07.31.20165647 23NguyenADavidJKMadenSKWoodMAWeederBRNelloreAHuman leukocyte antigen susceptibility map for" exact="severe acute respiratory syndrome" post="coronavirus 2J Virol94132020e00510e0052032303592 24RichardsonSHirschJSNarasimhanMCrawfordJMMcGinnTDavidsonKWPresenting characteristics, comorbidities, and outcomes among"/>
  <result pre="for COVID-19. A randomized clinical trialmedRxiv.2020202007.01.20139857 48HatesuerBBertramSMehnertNBahgatMMNelsonPSPohlmannSTmprss2 is essential for" exact="influenza" post="H1N1 virus pathogenesis in micePLoS Pathog92013e1003774 49YamamotoMMatsuyamaSLiXTakedaMKawaguchiYInoueJIIdentification of nafamostat"/>
  <result pre="cases of treatment with nafamostat in elderly patients with COVID-19" exact="pneumonia" post="who need oxygen therapyInt J Infect Dis96202050050232470602 51CortegianiAIppolitoMIngogliaGIozzoPGiarratanoAEinavSUpdate I."/>
  <result pre="double-blind, placebo-controlled, multicentre trialLancet39520201569157832423584 58AntinoriSCossuMVRidolfoALRechRBonazzettiCPaganiGCompassionate remdesivir treatment of severe Covid-19" exact="pneumonia" post="in intensive care unit (ICU) and Non-ICU patients: clinical"/>
 </snippets>
</snippetsTree>
